The action of purinergic antagonists on kainate-induced currents was studie
d in rat cortical neurons in primary culture using the whole-cell configura
tion of the patch-clamp technique. The amplitude of the currents induced by
kainate in cortical neurons was concentration-dependent (EC50 = 106 muM) P
yridoxal-phosphate-6-azophenyll-2',4'-disulphonic acid 4-sodium (PPADS), a
P2X antagonist, was ineffective in the reduction of the kainate-induced cur
rent in cortical neurons, while 2,2'-pyridylisatogen (PIT), basilen blue (B
B) and suramin, respectively two selective P2Y and a non-selective P7 recep
tor antagonist, caused a reduction in the amplitude of the current induced
by kainate. BB decreased the inward current induced by kainate at all holdi
ng potentials and the reduction was dose-dependent (EC50 = 34 muM). The tot
al conductance of the neurons for the kainate-induced current was significa
ntly reduced (P<0.01) and the effect was completely reversible. BB furtherm
ore reduced the kainate-induced current in granule and hippocampal neurons
and decreased the amplitude of the <alpha>-amino-3-hydroxy-5-methyl-4-isoxa
lepropionic acid (AMPA)-evoked current in cortical neurons. Cholera toxin (
ChTx) did not affect the action of BE on the kainate-induced currents in co
rtical neurons and moreover, when guanosine 5'-o-(3-thiotriphosphate) (GTP
gammaS) was added to the electrode solution, the kainate-induced currents w
ere still reduced by 100 muM BB. The maximal response to kainate decreased
in the presence of 20 muM BB without changing its EC50, indicating a non-co
mpetitive mechanism of inhibition. These results demonstrate that preferent
ial P2Y receptor antagonists are able to modulate the kainate and AMPA-indu
ced currents in central neurons, suggesting a potential use of these compou
nds as neuroprotective agents. (C) 2000 Elsevier Science B.V. All rights re
served.